Sacral nerve neuromodulation in patients with underlying neurologic disease
- PMID: 17618775
- DOI: 10.1016/j.ajog.2007.04.016
Sacral nerve neuromodulation in patients with underlying neurologic disease
Abstract
Objective: Sacral nerve neuromodulation (SNS) is an effective treatment for lower urinary tract dysfunction. Many underlying neurologic processes affect lower urinary tract function. We present results of SNS in patients with underlying neurologic dysfunction.
Study design: This is a retrospective case series of 33 patients with neurologic disease and lower urinary tract dysfunction who underwent an InterStim stimulation procedure. Results were evaluated by pre- and postoperative voiding diaries. Success was defined as greater than 50% improvement.
Results: Twenty-eight of 33 patients (85%) underwent implantation: 13 of 16 (81%) multiple sclerosis, 4 of 6 (67%) Parkinson disease, and 11 of 11 (100%) other neurologic disorders. Incontinence episodes per 24 hours decreased 68%, number of voids per 24 hours decreased 43%, nocturia decreased 70%, and there was a 58% reduction in intermittent self-catheterization per 24 hours. Ninety-three percent reported overall satisfaction.
Conclusion: Sacral nerve neuromodulation is an effective treatment for lower urinary tract dysfunction in patients with underlying neurologic disease.
Similar articles
-
Sacral nerve neuromodulation in patients with cardiac pacemakers.Am J Obstet Gynecol. 2007 Jul;197(1):94.e1-3. doi: 10.1016/j.ajog.2007.04.017. Am J Obstet Gynecol. 2007. PMID: 17618774
-
Preliminary results of sacral neuromodulation in 23 children.J Urol. 2006 Nov;176(5):2227-31. doi: 10.1016/j.juro.2006.07.013. J Urol. 2006. PMID: 17070300 Clinical Trial.
-
Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study.J Urol. 2007 Nov;178(5):2029-34. doi: 10.1016/j.juro.2007.07.032. Epub 2007 Sep 17. J Urol. 2007. PMID: 17869298 Clinical Trial.
-
How sacral nerve stimulation neuromodulation works.Urol Clin North Am. 2005 Feb;32(1):11-8. doi: 10.1016/j.ucl.2004.09.004. Urol Clin North Am. 2005. PMID: 15698871 Review.
-
The current use of neuromodulation for bladder dysfunction.Minerva Ginecol. 2006 Aug;58(4):283-93. Minerva Ginecol. 2006. PMID: 16957672 Review.
Cited by
-
The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction.Arab J Urol. 2018 Aug 7;16(4):391-396. doi: 10.1016/j.aju.2018.05.006. eCollection 2018 Dec. Arab J Urol. 2018. PMID: 30534437 Free PMC article.
-
The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.Curr Urol Rep. 2012 Oct;13(5):335-42. doi: 10.1007/s11934-012-0266-9. Curr Urol Rep. 2012. PMID: 22886612
-
Sacral neuromodulation enabling simultaneous pancreas and kidney transplantation: a first case.BMJ Case Rep. 2009;2009:bcr08.2008.0823. doi: 10.1136/bcr.08.2008.0823. Epub 2009 Feb 2. BMJ Case Rep. 2009. PMID: 21686612 Free PMC article.
-
Urinary tract dysfunction in Parkinson's disease: a review.Int Urol Nephrol. 2012 Apr;44(2):415-24. doi: 10.1007/s11255-011-9969-y. Epub 2011 May 7. Int Urol Nephrol. 2012. PMID: 21553114 Review.
-
Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future Directions.Adv Ther. 2021 Apr;38(4):1987-2006. doi: 10.1007/s12325-021-01650-9. Epub 2021 Mar 13. Adv Ther. 2021. PMID: 33713279 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
